The Biggest Gains Come After Year 10 ⏳ Everyone wants to double their money now. But real wealth in stocks doesn’t work that way. Amazon, Google, Tesla… all looked like “just okay” companies in their first 10 years. The real magic—96% of their total value—came after that. Why? Because compounding takes time. The early years are quiet. The late years are explosive. But most investors don’t wait long enough. They sell after 2 years of “meh” returns… Right before the rocket takes off. So what’s the lesson? If you’ve done the work and picked a great business—give it time. Holding through the boring years is what separates average investors from wealthy ones. 📈 In long-term investing, patience isn’t just a virtue—it’s a weapon. 🔥 Follow @masteringwealth & @goodstudent_investing for the best investing content on Instagram 🔥 Source & credits: NFX, 2022 📝Note: Post includes opinions, not investment advice. . . #investing101 #investingstrategy #stockmarkets #msft #aapl #applestock #dividends #tsla #teslastock #dividendgrowthstocks #microsoft #billgates #dividendinvesting #investingeducation #stockstowatch #stockstobuy #stockstohold #stockmarketnews #stockmarket #hustle #nyse #nasdaq #investing101 #stocks #stockstotrade #intelligentinvesting #elonmusk #stevejobs

Welcure Drugs (BSE: 524661) – Q1 FY25 Result Out! 📦 Revenue: ₹299.91 Cr 💰 Net Prof!t: ₹23.30 Cr 📊 EPS: ₹2.072 📈 10x jump from March prof!t of ₹2.53 Cr 🔹 Pure sourcing model – no debt, no inventory 🔹 ₹900+ Cr confirmed order book 🔹 Profit from ₹299 Cr order already booked ⚡ Stock price: just ₹12 📉 P/E < 5 vs sector avg 40+ 🔖 #WelcureDrugs #MultibaggerStock #PennyStockIndia #UndervaluedGems #SmallCapStock #StockMarketIndia #InvestSmart #ValueInvesting #WealthCreation #StockMarketNews #LongTermStocks #Q1Results #BSEIndia #StockAlert #FinancialIndependenceIndia

💥 Welcure Drugs (BSE: 524661) completed 300 cr order ✅ ₹900+ Cr sourcing orders in just 3 weeks ✅ 5% commission = ₹46 Cr revenue potential ✅ Zero debt, asset-light model 💰 Stock price just ₹12 — massively undervalued 📊 Forward P/E under 5 vs industry avg 40+ 🕒 Q1 results due soon — time to act before it flies! 🚀 📌 DYOR but this one screams multibagger potential! ⸻ 🔖 #WelcureDrugs #BSE524661 #MultibaggerStock #PennyStockIndia #UndervaluedGems #SmallCapStock #StockMarketIndia #InvestSmart #ValueInvesting #WealthCreation #StockMarketNews #LongTermStocks #Q1Results #BSEIndia #StockAlert #FinancialIndependenceIndia

Let’s take a look at the biggest winners and losers from the first six months of the year: Top Performers (YTD): 🟢 Palantir Technologies: +65.5% 🟢 Howmet Aerospace: +66.1% 🟢 CVS Health: +55.9% 🟢 Dollar General: +53.2% 🟢 Newmont Corporation: +52.1% Biggest Declines (YTD): 🔴 UnitedHealth Group: -38.4% 🔴 Lululemon: -38.4% 🔴 West Pharmaceutical Services: -34.3% 🔴 Dow Inc.: -34.0% 🔴 Tesla: -31.3% Any surprises on your radar? #stockmarket #investing #finance #stocks #trading #stocknews #marketupdate #wealthbuilding #financialfreedom #SP500 #investor #stockmarketnews #traderlife #stockperformance #economicnews #longterminvesting #techstocks #wallstreet

The White House has confirmed that the total tariffs imposed by the United States on Chinese imports have surged to 145%. This increase includes a 125% "reciprocal" tariff and an additional 20% penalty related to China's alleged role in the U.S. fentanyl crisis. The move marks a significant escalation in trade tensions between the two economic giants and has sparked concern among global markets and policymakers. In response, China has retaliated with its own 84% tariffs on U.S. goods and imposed restrictions on 18 American companies. The escalation has drawn criticism from several quarters, including former U.S. Treasury Secretary Janet Yellen, who labeled the tariff strategy as the "worst self-inflicted wound" by any successful economy. Economists warn that the growing trade war could severely impact global supply chains, trade flows, and market stability. The World Trade Organization has even cautioned that continued conflict may reduce U.S.-China trade by up to 80%. Meanwhile, stock markets have experienced sharp swings, with initial optimism fading quickly as investors digested the full scope of the tariff hikes. ⚠️⚠️⚠️ Disclaimer: NO COPYRIGHT INFRINGEMENT INTENDED! We do not own the rights to this video and photo used in this reel and post. All credit goes to the original creator. This video is shared for informational purposes only. If you are the owner and wish to discuss this content, please DM or email us. FAIR USE: Copyright disclaimer under section 107 of the copyright act 1976. Allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship infringing." We do not own all the material. . . . #news #worldnews #worldinlast24hr #explore #explorepage #trending #USTariffs #ChinaTrade #TradeWar2025 #GlobalEconomy #StockMarketNews #TariffTensions #FentanylCrisis #WTOWarning